Verdence Capital Advisors LLC increased its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 8.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 48,659 shares of the company’s stock after purchasing an additional 3,825 shares during the period. Verdence Capital Advisors LLC’s holdings in Procter & Gamble were worth $7,069,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in PG. Baxter Bros Inc. purchased a new stake in Procter & Gamble in the second quarter valued at approximately $12,381,000. Empowered Funds LLC acquired a new stake in shares of Procter & Gamble in the second quarter valued at about $53,549,000. Bank of America Corp DE purchased a new stake in shares of Procter & Gamble during the second quarter valued at approximately $3,850,628,000. Rokos Capital Management LLP acquired a new position in Procter & Gamble in the 1st quarter worth $29,914,000. Finally, Capstone Capital Management Ltd acquired a new position in shares of Procter & Gamble in the third quarter worth about $991,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Activity
In other Procter & Gamble news, CEO Paul Gama sold 4,331 shares of the business’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $161.27, for a total transaction of $698,460.37. Following the completion of the transaction, the chief executive officer owned 46,793 shares in the company, valued at approximately $7,546,307.11. The trade was a 8.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Susan Whaley sold 2,369 shares of the company’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the completion of the sale, the insider directly owned 30,730 shares of the company’s stock, valued at $4,466,298.20. The trade was a 7.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 58,647 shares of company stock worth $9,268,508 over the last ninety days. 0.23% of the stock is currently owned by company insiders.
Procter & Gamble Stock Down 0.7%
Shares of NYSE:PG opened at $159.96 on Tuesday. The stock has a market capitalization of $370.75 billion, a price-to-earnings ratio of 24.09, a price-to-earnings-growth ratio of 4.00 and a beta of 0.39. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25. The company’s fifty day moving average is $148.38 and its two-hundred day moving average is $148.47. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.53 and a current ratio of 0.72.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The company had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. During the same period in the previous year, the firm posted $1.99 earnings per share. Procter & Gamble’s quarterly revenue was up 4.0% compared to the same quarter last year. Equities analysts anticipate that Procter & Gamble Company will post 6.98 EPS for the current year.
Procter & Gamble Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be issued a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s payout ratio is 65.51%.
Analyst Upgrades and Downgrades
A number of research firms have commented on PG. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Procter & Gamble in a research note on Friday. Royal Bank Of Canada set a $169.00 price objective on Procter & Gamble in a research note on Friday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a report on Monday, September 21st. BNP Paribas Exane increased their target price on Procter & Gamble from $177.00 to $189.00 and gave the stock an “outperform” rating in a report on Friday. Finally, BMO Capital Markets lifted their target price on Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a research report on Monday, June 29th. Fifteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $170.57.
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Exchange-traded funds purchased approximately $82.8 million of PG stock on October 22, indicating institutional demand and potentially providing support for the shares. ETFs Bought $82.8 Million of Procter & Gamble
- Positive Sentiment: Several analysts remain constructive: JPMorgan raised its price target, while TD Cowen, BNP Paribas Exane and Citigroup reportedly forecast further appreciation. Freedom Broker also upgraded PG to Buy. JPMorgan Price Target Increase TD Cowen Forecast
- Positive Sentiment: Investment commentary highlights PG’s strong household-product market shares and appeal as a high-yield, defensive dividend stock—factors that may attract income-oriented investors. High-Yield Dividend Stock Comparison
- Neutral Sentiment: Articles comparing PG with Colgate-Palmolive and discussing TIPS, Treasury bills and dividend stocks reinforce PG’s defensive and income-investment appeal, but provide limited new company-specific information. PG Versus CL
- Negative Sentiment: Higher oil prices could raise manufacturing, packaging, transportation and other costs. Unless offset by pricing or productivity gains, this would pressure PG’s margins and earnings outlook. Impact of Higher Oil Prices
- Negative Sentiment: Insiders reported notable selling: Shailesh Jejurikar sold 35,000 shares worth about $5.7 million, while other executives sold shares as well. These transactions are not necessarily bearish, but the reductions in ownership can create a modest sentiment overhang. SEC Insider Filing
Procter & Gamble Company Profile
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
See Also
- Five stocks we like better than Procter & Gamble
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
